• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病肾病中的肾脏内皮细胞。

The renal endothelium in diabetic nephropathy.

机构信息

Department of Nephrology, Medical School, University of Thessaly, Larissa, Greece.

出版信息

Ren Fail. 2013;35(4):592-9. doi: 10.3109/0886022X.2013.773836. Epub 2013 Mar 11.

DOI:10.3109/0886022X.2013.773836
PMID:23472883
Abstract

Diabetic nephropathy is the leading cause of end-stage renal disease. Diabetes mellitus is characterized by generalized endothelial dysfunction. However, recent data also emphasizes the role of local renal endothelium dysfunction in the pathogenesis of diabetic nephropathy. Hyperglycemia triggers a complex network of signal-transduction molecules, transcription factors, and mediators that culminate in endothelial dysfunction. In the glomerulus, vascular endothelial growth factor-A (VEGF)-induced neoangiogenesis may contribute to the initial hyperfiltration and microalbuminuria due to increased filtration area and immaturity of the neovessels, respectively. However, subsequent decrease in podocytes number decreases VEGF production resulting in capillary rarefaction and decreased glomerular filtration rate (GFR). Decreased nitric oxide availability also plays a significant role in the development of advanced lesions of diabetic nephropathy through disruption of glomerular autoregulation, uncontrolled VEGF action, release of prothrombotic substances by endothelial cells and angiotensin-II-independent aldosterone production. In addition, disturbances in endothelial glycocalyx contribute to decreased permselectivity and microalbuminuria; whereas there are recent evidences that reduced glomerular fenestral endothelium leads to decreased GFR levels. Endothelial repair mechanisms are also impaired in diabetes, since circulating endothelial progenitor cells number is decreased in diabetic patients with microalbuminuria. Finally, in the context of elevated profibrotic cytokine transforming growth factor-β levels, endothelial cells also confer to the deteriorating process of fibrosis in advanced diabetic nephropathy through endothelial to mesenchymal transition.

摘要

糖尿病肾病是终末期肾病的主要原因。糖尿病的特征是全身性内皮功能障碍。然而,最近的数据也强调了局部肾脏内皮功能障碍在糖尿病肾病发病机制中的作用。高血糖引发了一系列信号转导分子、转录因子和介质的复杂网络,最终导致内皮功能障碍。在肾小球中,血管内皮生长因子-A(VEGF)诱导的新生血管可能导致初始高滤过和微量白蛋白尿,分别是由于滤过面积增加和新生血管不成熟。然而,随后 podocytes 数量的减少会导致 VEGF 产生减少,从而导致毛细血管稀疏和肾小球滤过率(GFR)降低。一氧化氮供应的减少也通过破坏肾小球自身调节、不受控制的 VEGF 作用、内皮细胞释放促血栓物质和独立于血管紧张素-II 的醛固酮产生,在糖尿病肾病的晚期病变发展中起重要作用。此外,内皮糖萼的紊乱也导致了滤过选择性降低和微量白蛋白尿;而最近有证据表明,肾小球裂孔内皮的减少导致 GFR 水平降低。在升高的促纤维化细胞因子转化生长因子-β水平的情况下,内皮细胞也通过内皮向间充质转化,导致晚期糖尿病肾病纤维化的恶化过程。

相似文献

1
The renal endothelium in diabetic nephropathy.糖尿病肾病中的肾脏内皮细胞。
Ren Fail. 2013;35(4):592-9. doi: 10.3109/0886022X.2013.773836. Epub 2013 Mar 11.
2
Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.糖尿病肾小球病中足细胞病和蛋白尿的发病机制。
Curr Diabetes Rev. 2008 Feb;4(1):39-45. doi: 10.2174/157339908783502370.
3
Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man.在人类糖尿病肾病期间,局部血管内皮生长因子(VEGF)活性而非VEGF表达受到严格调控。
Kidney Int. 2006 May;69(9):1654-61. doi: 10.1038/sj.ki.5000294.
4
Relationships among microalbuminuria, insulin resistance and renal-cardiac complications in insulin dependent and non insulin dependent diabetes.胰岛素依赖型和非胰岛素依赖型糖尿病中微量白蛋白尿、胰岛素抵抗与肾心并发症之间的关系。
Exp Clin Endocrinol Diabetes. 1997;105 Suppl 2:1-7. doi: 10.1055/s-0029-1211783.
5
Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy.糖尿病内皮型一氧化氮合酶基因敲除小鼠会发展为晚期糖尿病肾病。
J Am Soc Nephrol. 2007 Feb;18(2):539-50. doi: 10.1681/ASN.2006050459. Epub 2007 Jan 3.
6
Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients.罗格列酮可改善患者早期糖尿病肾病的肾小球高滤过、肾内皮功能障碍及微量白蛋白尿。
Diabetes. 2005 Jul;54(7):2206-11. doi: 10.2337/diabetes.54.7.2206.
7
Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy.传入和肾小球内皮细胞中内皮细胞一氧化氮合酶(ecNOS)表达增加与糖尿病肾病的肾小球高滤过有关。
Diabetologia. 1998 Dec;41(12):1426-34. doi: 10.1007/s001250051088.
8
The endothelium in diabetic nephropathy.糖尿病肾病中的内皮细胞。
Semin Nephrol. 2012 Mar;32(2):199-207. doi: 10.1016/j.semnephrol.2012.02.006.
9
Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy.人1型糖尿病肾病中的足细胞脱离和肾小球毛细血管内皮窗孔减少
Diabetes. 2007 Aug;56(8):2155-60. doi: 10.2337/db07-0019. Epub 2007 May 29.
10
Nephrin and endothelial injury.nephrin与内皮损伤。
Curr Opin Nephrol Hypertens. 2009 Jan;18(1):3-8. doi: 10.1097/MNH.0b013e32831a4713.

引用本文的文献

1
Apelin/APJ alleviates diabetic nephropathy by improving glomerular endothelial cells dysfunction via SIRT3‑KLF15.Apelin/APJ通过SIRT3-KLF15改善肾小球内皮细胞功能障碍来减轻糖尿病肾病。
Mol Med Rep. 2025 May;31(5). doi: 10.3892/mmr.2025.13487. Epub 2025 Mar 7.
2
Research Progress on the Anticancer Activity of Plant Polysaccharides.植物多糖抗癌活性的研究进展
Recent Pat Anticancer Drug Discov. 2024;19(5):573-598. doi: 10.2174/1574892819666230915103434.
3
Sodium Butyrate as Key Regulator of Mitochondrial Function and Barrier Integrity of Human Glomerular Endothelial Cells.
丁酸钠作为人肾小球内皮细胞线粒体功能和屏障完整性的关键调节因子。
Int J Mol Sci. 2023 Aug 23;24(17):13090. doi: 10.3390/ijms241713090.
4
Anti-oxidant, anti-apoptotic, and protective effects of myricitrin and its solid lipid nanoparticle on streptozotocin-nicotinamide induced diabetic nephropathy in type 2 diabetic male mice.杨梅素及其固体脂质纳米粒对链脲佐菌素-烟酰胺诱导的2型糖尿病雄性小鼠糖尿病肾病的抗氧化、抗凋亡和保护作用。
Iran J Basic Med Sci. 2023;26(8):851-853. doi: 10.22038/IJBMS.2023.22499.
5
Dapagliflozin Prevents High-Glucose-Induced Cellular Senescence in Renal Tubular Epithelial Cells.达格列净可预防高糖诱导的肾小管上皮细胞衰老。
Int J Mol Sci. 2022 Dec 17;23(24):16107. doi: 10.3390/ijms232416107.
6
Re-understanding and focusing on normoalbuminuric diabetic kidney disease.重新认识并关注正常白蛋白尿的糖尿病肾脏疾病。
Front Endocrinol (Lausanne). 2022 Dec 2;13:1077929. doi: 10.3389/fendo.2022.1077929. eCollection 2022.
7
Molecular Aspects of Renal Immunology: Current Status and Future Perspectives.肾脏免疫学的分子方面:现状与未来展望。
Int J Mol Sci. 2022 Apr 6;23(7):4040. doi: 10.3390/ijms23074040.
8
Novel Protein Therapeutics Created Using the Elastin-Like Polypeptide Platform.利用弹性蛋白样多肽平台开发的新型蛋白质治疗药物。
Physiology (Bethesda). 2021 Nov 1;36(6):367-381. doi: 10.1152/physiol.00026.2021. Epub 2021 Sep 6.
9
The Endothelial Glycocalyx as a Target of Ischemia and Reperfusion Injury in Kidney Transplantation-Where Have We Gone So Far?内皮糖萼作为肾移植中缺血再灌注损伤的靶点:我们已经走了多远?
Int J Mol Sci. 2021 Feb 22;22(4):2157. doi: 10.3390/ijms22042157.
10
Diabetic Nephropathy: Novel Molecular Mechanisms and Therapeutic Targets.糖尿病肾病:新的分子机制与治疗靶点
Front Pharmacol. 2020 Dec 21;11:586892. doi: 10.3389/fphar.2020.586892. eCollection 2020.